IDEX Corp

US · IEX #1045 by market cap Listed 1970

232.91 -3.37 -1.43%

Live - 5344 symbols - heartbeat 125s ago · 2026-10-08 07:39

Pre-market 230.73 -0.94%

After-hours 232.91 0.00%

Market cap: 17.17B
P/E (TTM): 33.51
P/B: 4.28
EPS: 6.41
Div yield: 1.54%
52W pos: 88%

Reader sentiment Are you bullish or bearish on IEX?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Good

Altman Z-Score is 5.49, above the 3.0 "safe zone" threshold.
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +5.77% YoY

Margins

Gross margin: 44.51%
Operating margin: 20.82%
Net margin: 13.98%

Key ratios & quality

Enterprise value: 18.44B
Altman Z-Score: 5.49

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	2.48B	2.49B	2.35B	2.76B	3.18B	3.27B	3.27B	3.46B
Gross profit	1.12B	1.13B	1.03B	1.22B	1.43B	1.45B	1.45B	1.54B
Selling & admin expenses	536.72M	525.00M	494.90M	578.20M	652.70M	703.50M	758.70M	818.80M
Research & development	--	--	--	--	--	--	--	--
Operating profit	581.17M	600.00M	532.50M	646.30M	774.20M	743.40M	686.50M	720.00M
Pretax profit	528.94M	532.90M	470.30M	579.80M	749.40M	760.30M	639.30M	632.60M
Tax	118.37M	107.40M	92.50M	130.50M	162.70M	164.70M	134.70M	150.10M
Net profit	410.57M	425.50M	377.80M	449.30M	586.70M	595.60M	504.60M	482.50M
Basic EPS	5	6	5	6	8	8	7	6
Diluted EPS	5.29	5.56	4.94	5.88	7.71	7.85	6.64	6.41

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Revenue	814.30M	865.40M	878.70M	899.10M	886.90M	920.60M
Gross profit	368.90M	392.20M	390.60M	387.10M	398.10M	426.80M
Selling & admin expenses	209.40M	203.60M	204.70M	201.10M	218.30M	224.10M
Research & development	--	--	--	--	--	--
Operating profit	159.50M	188.60M	185.90M	186.00M	179.80M	202.70M
Pretax profit	124.50M	169.90M	170.50M	167.70M	157.00M	186.10M
Tax	29.10M	38.80M	42.80M	39.40M	37.10M	42.70M
Net profit	95.40M	131.10M	127.70M	128.30M	119.90M	143.40M
Basic EPS	1	2	2	2	2	2
Diluted EPS	1.26	1.74	1.70	1.71	1.61	1.93

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	1.09B	1.26B	1.66B	1.68B	1.40B	1.45B	1.59B	1.64B
Cash & ST investments	466.41M	632.58M	1.03B	855.40M	430.20M	534.30M	620.80M	580.00M
Inventory	280.00M	293.47M	289.90M	370.40M	470.90M	420.80M	429.70M	479.40M
Total assets	3.47B	3.81B	4.41B	4.92B	5.51B	5.87B	6.75B	6.93B
Total current liabilities	364.66M	357.88M	399.00M	480.00M	543.60M	500.30M	629.70M	575.40M
Short-term debt	483.00K	15.62M	16.80M	17.60M	21.60M	22.60M	126.80M	28.50M
Long-term debt	848.34M	848.86M	1.04B	1.19B	1.47B	1.33B	1.86B	1.82B
Total liabilities	1,479,217,000.00	1,550,683,000.00	1,874,100,000.00	2,114,100,000.00	2,472,300,000.00	2,324,000,000.00	2,951,200,000.00	2,900,800,000.00
Total equity	1.99B	2.26B	2.54B	2.80B	3.04B	3.54B	3.79B	4.03B
Retained earnings	2.34B	2.62B	2.84B	3.13B	3.53B	3.93B	4.23B	4.50B

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Total current assets	1.63B	1.62B	1.65B	1.64B	1.72B	1.77B
Cash & ST investments	594.10M	568.20M	593.80M	580.00M	586.20M	621.30M
Inventory	466.30M	487.80M	495.10M	479.40M	501.00M	520.30M
Total assets	6.80B	6.88B	6.97B	6.93B	6.92B	6.93B
Total current liabilities	583.60M	529.80M	564.00M	575.40M	506.00M	581.60M
Short-term debt	127.30M	28.50M	28.10M	28.50M	27.50M	27.00M
Long-term debt	1.84B	1.85B	1.90B	1.82B	1.87B	1.86B
Total liabilities	2,889,200,000.00	2,865,700,000.00	2,959,600,000.00	2,900,800,000.00	2,870,200,000.00	2,923,400,000.00
Total equity	3.91B	4.01B	4.01B	4.03B	4.05B	4.01B
Retained earnings	4.33B	4.35B	4.42B	4.50B	4.62B	4.66B

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	479.35M	528.10M	569.30M	565.30M	557.40M	716.70M	668.10M	680.40M
Depreciation & amortization	77.54M	76.90M	83.50M	103.00M	119.70M	152.10M	175.60M	206.50M
Free cash flow	419.26M	477.20M	517.70M	492.60M	489.40M	626.80M	603.00M	616.80M
Dividends paid	-127.48M	-147.20M	-151.80M	-161.10M	-177.40M	-190.70M	-205.30M	-212.60M
Stock buybacks / issuance	-173.93M	-54.70M	-110.30M	13.60M	-134.00M	-2.70M	16.70M	-248.30M
Ending cash balance	466.41M	632.60M	1.03B	855.40M	430.20M	534.30M	638.90M	585.90M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Operating cash flow	105.70M	161.70M	203.50M	209.50M	103.70M	200.00M
Depreciation & amortization	49.90M	51.00M	52.10M	53.50M	53.70M	53.40M
Free cash flow	91.40M	146.90M	188.70M	189.80M	86.00M	177.00M
Dividends paid	-52.40M	-53.50M	-53.50M	-53.20M	-52.80M	-53.90M
Stock buybacks / issuance	-50.50M	-49.70M	-76.00M	-72.10M	-70.50M	-72.30M
Ending cash balance	612.20M	570.00M	599.70M	585.90M	591.80M	628.10M

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	21.16	19.99	15.73	16.82	20.09	18.12	13.77	12.35
ROA %	11.95	11.68	9.18	9.63	11.26	10.48	8.01	7.07
ROIC %	15.88	15.23	12.00	12.34	14.17	13.24	10.03	9.13
5-year avg ROE %	19.31	19.65	18.94	18.67	18.76	18.15	16.91	16.23
EBIT margin %	23.07	23.14	21.90	22.45	24.83	24.80	20.92	20.16
FCF / sales %	16.88	19.13	22.02	17.82	15.38	19.15	18.45	17.84
Current ratio	3.00	3.52	4.15	3.50	2.57	2.89	2.53	2.86
Quick ratio	2.14	2.60	3.31	2.52	1.61	1.92	1.73	1.91
Debt / assets	24.77	24.50	26.18	26.46	28.79	22.98	29.45	26.69
LT debt / equity	43.11	40.60	44.83	45.80	51.50	37.42	49.00	45.19
Interest coverage	12.98	13.02	11.51	15.14	19.41	15.71	15.37	10.82
Revenue CAGR (3Y) %	7.12	5.69	0.93	3.64	8.45	11.66	5.74	2.81
Net income CAGR (3Y) %	13.23	16.21	3.86	3.06	11.32	16.42	3.96	-6.28
FCF CAGR (3Y) %	9.82	9.68	10.01	5.52	0.85	6.58	6.97	8.02

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
ROE %	12.73	12.25	12.21	12.35	12.76	12.96
ROA %	7.55	7.35	6.86	7.07	7.40	7.53
ROIC %	9.58	9.49	8.91	9.13	9.42	9.65
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	20.12	19.72	19.90	20.16	20.66	20.78
FCF / sales %	16.99	17.57	17.07	17.84	17.32	17.89
Current ratio	2.79	3.05	2.93	2.86	3.39	3.05
Quick ratio	1.84	1.97	1.94	1.91	2.25	2.01
Debt / assets	28.94	27.28	27.69	26.69	27.45	27.21
LT debt / equity	47.08	46.04	47.40	45.19	46.22	46.37
Interest coverage	12.90	11.22	10.49	10.82	11.34	11.68
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Lead segment, long tail

Health & Science Technologies (HST) is the largest reported line at 45.08% of revenue, across 4 reported segments.
Fluid & Metering Technologies (FMT) follows at 34.44%, so the top line still matters most but isn’t the whole story.

Revenue breakdown most recent period

Business

Health & Science Technologies (HST)45.08%

Fluid & Metering Technologies (FMT)34.44%

Fire & Safety/Diversified Products (FSDP)20.63%

Quote time 2026-10-08 07:39:34 · For reference only, not investment advice and not tailored to your situation.